0
Topadur has appointed Matthias Schäfer as CEO
Topadur Pharma, a clinical-stage biotechnology company specialising in therapies for vascular regeneration, has announced the appointment of Dr Matthias Schäfer as CEO.
Schäfer brings over two decades of experience across the life sciences and healthcare sectors to his new role. His expertise spans research, clinical development, strategic partnerships and portfolio expansion. Schäfer joined Topadur in 2024 as Chief Innovation Officer and Deputy CEO. He has held senior leadership roles at Geistlich Pharma and pfm medical, where he strengthened…